MilliporeSigma

Intensified & Continuous Upstream (USP) Processing

Future-proof your manufacturing strategies, reduce costs and increase facility flexibility with intensified fed-batch and perfusion processes

HomeIntegrated OfferingsBiopharma 4.0Intensified and Continuous Upstream (USP) ProcessingSeed Train Intensification

 

Biopharmaceutical developers and manufacturers need efficient, productive upstream processes that deliver high quality monoclonal antibodies (mAbs) and other types of recombinant proteins. Process intensification, including intensified fed-batch and perfusion processes, can future-proof their manufacturing strategies, reduce costs, and increase facility flexibility.

With a full suite of solutions designed to support the increased demands of intensified upstream processes and technical support from teams with years of experience, we can help you realize the benefits of upstream process intensification without compromising clinical milestones or speed to market.

Seed Train Intensification

The traditional seed train process is time- and labor-intensive, requiring operators to transfer and manually cultivate the cells as they generate biomass to inoculate the production bioreactor. The manual transfer of cells between vessels also creates an increased risk of contamination.

Seed train intensification increases facility flexibility and reduces operator hands-on time, improving efficiency and reducing risk. This can be achieved in two ways, both of which are compatible with fed-batch and perfusion production processes:

  • Perfusion operations in the seed train, which reach significantly higher cell densities than batch-based processes;
  • Incorporation of high volume, high cell density cryopreservation sample bags to decouple manual inoculum train and bioreactor seed train processes, reducing steps, achieving time savings and enabling closed process operations.

The BioContinuum™ Seed Train Platform is the solution to intensify your seed train during mAb production.

The platform includes:

With these products, technical support, and application studies designed to address diverse manufacturing scenarios, mAb manufacturers can accelerate upstream process development and confidently scale up to clinical and commercial volumes.


Related Products
Loading

Related Categories

Bioprocessing Cell Culture Media
Bioprocessing Cell Culture Media

With our comprehensive portfolio, you can choose from tried-and-true formulations...

The Mobius® Single-Use Bioreactor family of products can be seen.
Bioprocessing Mobius® Single-Use Bioreactors

Mobius® products and solutions can help you meet your evolving cell culture needs...

A scientist works on a bioreactor while sitting at a white counter next to a window.
Cell Retention

Perfusion operations deliver high-density cell cultures that alleviate the burden of processing large production bioreactor...

Mobius® 3D Bag Assembly in 3D Large Liquid Transport Bin
Single-Use Assemblies

Streamline biopharma manufacturing with Mobius® 2D and 3D single-use assemblies.


Related Resources

Page 1 of 2

Related Webinars

Implementing High Cell Density Cryopreservation in Your Intensified Seed Train

Explore the use and benefits of a high cell density cryopreservation (HCDC)

Enabling Upstream Intensified Bioprocessing

Intensified upstream bioprocesses are being developed to increase productivity while...

A Cost Analysis and Evaluation of Perfused Seed Train Scenarios Through Process Modeling

Learn how perfused seed train options could deliver lower cost of goods, increase product throughput, or a combination of both.

Cold hard facts: Implementing high cell density cryopreservation in your intensified seed train

The integration of a perfused N-1 step in upstream process is highlighted to either decrease facility footprint or to be able to inoculate final fed-batch N-stage with a higher cell density as a conventional fed-batch.

Media and process development for seed train intensification

Media composition plays a critical role for biopharmaceutical production as well as seed train expansion.

The BioContinuum™ Seed Train Platform

Upstream process intensification can bring significant benefits to manufacturers in terms of smaller facilities, manufacturing flexibility, and reduction in footprint, with achieving significantly higher productivity.


Related Videos



BioContinuum™ Platform: Your enabler of the biomanufacturing facility of the future!

Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?